BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17210730)

  • 1. Igkappa allelic inclusion is a consequence of receptor editing.
    Casellas R; Zhang Q; Zheng NY; Mathias MD; Smith K; Wilson PC
    J Exp Med; 2007 Jan; 204(1):153-60. PubMed ID: 17210730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic and isotypic light chain inclusion in peripheral B cells from anti-DNA antibody transgenic C57BL/6 and BALB/c mice.
    Witsch EJ; Bettelheim E
    J Immunol; 2008 Mar; 180(6):3708-18. PubMed ID: 18322176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of receptor editing to the antibody repertoire.
    Casellas R; Shih TA; Kleinewietfeld M; Rakonjac J; Nemazee D; Rajewsky K; Nussenzweig MC
    Science; 2001 Feb; 291(5508):1541-4. PubMed ID: 11222858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for antigen receptor gene rearrangement. III. Heavy and light chain allelic exclusion.
    Kalmanovich G; Mehr R
    J Immunol; 2003 Jan; 170(1):182-93. PubMed ID: 12496399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models for antigen receptor gene rearrangement. I. Biased receptor editing in B cells: implications for allelic exclusion.
    Mehr R; Shannon M; Litwin S
    J Immunol; 1999 Aug; 163(4):1793-8. PubMed ID: 10438911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced kappa receptor editing shows no allelic preference in a mouse pre-B cell line.
    Liu X; Linden M; Van Ness B
    J Immunol; 2000 Dec; 165(12):7058-63. PubMed ID: 11120834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.
    Prak EL; Trounstine M; Huszar D; Weigert M
    J Exp Med; 1994 Nov; 180(5):1805-15. PubMed ID: 7964462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor editing and genetic variability in human autoreactive B cells.
    Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
    J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ataxia telangiectasia mutated kinase controls Igκ allelic exclusion by inhibiting secondary Vκ-to-Jκ rearrangements.
    Steinel NC; Lee BS; Tubbs AT; Bednarski JJ; Schulte E; Yang-Iott KS; Schatz DG; Sleckman BP; Bassing CH
    J Exp Med; 2013 Feb; 210(2):233-9. PubMed ID: 23382544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell receptor editing in tolerance and autoimmunity.
    Azulay-Debby H; Melamed D
    Front Biosci; 2007 Jan; 12():2136-47. PubMed ID: 17127450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity?
    Pelanda R
    Curr Opin Immunol; 2014 Apr; 27():53-9. PubMed ID: 24549093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating human B cells that express surrogate light chains and edited receptors.
    Meffre E; Davis E; Schiff C; Cunningham-Rundles C; Ivashkiv LB; Staudt LM; Young JW; Nussenzweig MC
    Nat Immunol; 2000 Sep; 1(3):207-13. PubMed ID: 10973277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance-induced receptor selection: scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection.
    Aït-Azzouzene D; Skog P; Retter M; Kouskoff V; Hertz M; Lang J; Kench J; Chumley M; Melamed D; Sudaria J; Gavin A; Martensson A; Verkoczy L; Duong B; Vela J; Nemazee D; Alfonso C
    Immunol Rev; 2004 Feb; 197():219-30. PubMed ID: 14962198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.
    Palmer VL; Aziz-Seible R; Kassmeier MD; Rothermund M; Perry GA; Swanson PC
    J Immunol; 2015 Aug; 195(4):1524-37. PubMed ID: 26150531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.